BIO-TECHNE Corp Commitments Disclosure
| 2020 | $ | 13,707 | ||
| 2021 | 13,469 | |||
| 2022 | 13,154 | |||
| 2023 | 12,716 | |||
| 2024 | 11,392 | |||
| Thereafter | 51,895 | |||
| Total | $ | 116,333 |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2019 | Aug 28, 2019 | Showing above |
| 2018 | Aug 27, 2018 | |
| 2017 | Sep 7, 2017 | |
| 2016 | Aug 29, 2016 | |
About Commitments Disclosures
Commitments and contingencies disclosures catalog a company's off-balance-sheet obligations and legal exposures — purchase commitments, guarantee arrangements, pending litigation, and regulatory proceedings. These items represent potential future cash outflows that may not appear as liabilities on the balance sheet until they become probable and estimable.
Key signals: litigation reserves and disclosed loss ranges quantify management's estimate of legal exposure, but unquantified "reasonably possible" losses often represent the larger risk. Watch for changes in language around pending cases — shifts from "remote" to "reasonably possible" or increases in estimated loss ranges signal deteriorating outcomes. Unconditional purchase obligations and take-or-pay contracts create fixed cost structures that reduce operational flexibility. Guarantee arrangements for subsidiaries or joint ventures can create cascading obligations. Compare the total commitment schedule against projected free cash flow to assess whether the company can meet its obligations without additional financing.